Evidence map›Paper›PMID 32962402›Full record

ArticleAnnals of the American Thoracic Society2021

The Impact of Antifungal Prophylaxis in Lung Transplant Recipients.

Kelly M Pennington, Hayley J Dykhoff, Xiaoxi Yao, Lindsey R Sangaralingham, Nilay D Shah, Steve G Peters, Jason N Barreto, Raymund R Razonable, Cassie C Kennedy

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of the American Thoracic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  2. Article
  3. Article
  4. Review
  5. Fungal infections in lung transplantation.Journal of thoracic disease · 2021
    Review
  6. Antifungal Prophylaxis.Annals of the American Thoracic Society · 2021
    Article
  7. Reply: Antifungal Prophylaxis.Annals of the American Thoracic Society · 2021
    Article
  8. Review
  9. An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients.Transplant infectious disease : an official journal of the Transplantation Society
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Kelly M PenningtonDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Hayley J DykhoffRobert D. and Patricia E. Kern Center for the Science of Healthcare Delivery.
Xiaoxi YaoRobert D. and Patricia E. Kern Center for the Science of Healthcare Delivery.
Lindsey R SangaralinghamRobert D. and Patricia E. Kern Center for the Science of Healthcare Delivery.
Nilay D ShahRobert D. and Patricia E. Kern Center for the Science of Healthcare Delivery.
Steve G PetersDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Jason N BarretoDepartment of Pharmacy, and.
Raymund R RazonableWilliam J. von Liebig Center for Transplantation and Clinical Regeneration.
Cassie C KennedyDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Pulmonary and Critical Care Associates · USDepartment of Medical Sciences · BYMayo Clinic · USMayo Clinic in Florida · USOptum (United States) · US

Funding

PA-20-072: Accelerating the Use of Evidence-based Innovation in Healthcare SystemsU19HS024075 · AHRQ · DARTMOUTH COLLEGE · PI MEARA, ELLEN R. · 2015 to 2021
$19.8M
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)R01HL131535 · NHLBI · MAYO CLINIC ROCHESTER · PI MONTORI, VICTOR MANUEL · 2016 to 2020
$3.2M
Gastrointestinal Safety of Antithrombotic Drug RegimensR01HS025402 · AHRQ · MAYO CLINIC ARIZONA · PI ABRAHAM, NEENA S · 2017 to 2020
$1.6M
Medical reversals: De-implementing ineffective and unsafe treatmentsR01HS025164 · AHRQ · UNIVERSITY OF MINNESOTA · PI KARACA-MANDIC, PINAR · 2017 to 2020
$1.4M
Exploring the Unmeasured Risk and Treating the Untreated Prognostic Factor: Towards Candidate Optimization in Heart and Lung TransplantK23HL128859 · NHLBI · MAYO CLINIC ROCHESTER · PI KENNEDY, CASSIE COLLEEN · 2016 to 2020
$854k
Diffusion of Clinical Evidence into Practice: Physician Networks, Delivery Organizations, and MarketsR56HL130496 · NHLBI · UNIVERSITY OF MINNESOTA · PI KARACA-MANDIC, PINAR · 2016 to 2016
$634k
Optimizing Medical Device Post-Market Surveillance for Public ValueU01FD004585 · FDA · YALE UNIVERSITY · PI KRUMHOLZ, HARLAN MARC · 2012 to 2016
$592k
The ICAN Discussion Aid to Optimize Treatment for People Living with Multiple Chronic ConditionsR03HS025517 · AHRQ · MAYO CLINIC ROCHESTER · PI SHAH, NILAY D · 2017 to 2018
$100k
AHRQ HHS R01 HS025164AHRQ HHS R01 HS025402AHRQ HHS R03 HS025517AHRQ HHS U19 HS024075FDA HHS U01 FD004585NHLBI NIH HHS K23 HL128859NHLBI NIH HHS R01 HL131535NHLBI NIH HHS R56 HL130496
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsInvasive Fungal InfectionsAdultHumansLungRetrospective StudiesTransplant RecipientsAntifungal Agentsantifungal prophylaxisAspergillusfungal infectionslung transplanttriazole

Identifiers

PMID32962402
PMCPMC7919156
OpenAlexW3088027053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.